« Return to News

Agrinos' Fourth quarter and full year 2014 Interim Report Announcement and Conference Call


  • A year of consolidation, reorganization and corporate development activities.
  • Q4 sales revenue at USD 1.9m and cash collection at USD 1.7m reflect current business seasonality.
  • FY 2014 sales revenue of USD 6.7m, a 55% increase over FY 2013 sales revenue
  • Douglas Ry Wagner announced as CEO, and John Janczak announced as CFO, as several key corporate functions move to the U.S.
  • Nick Adamchak, General Manager of Ameropa North America, joined the Board of Directors
  • Opened Global R&D Facility in Davis, California.
  • Additional financing of USD 17.4m to support continued growth strategy. This consisted of USD 15.3m successful convertible bond issue and USD 2.0m from bridge loan subscription rights conversion.

“2014 was year of great progress for Agrinos in reorganizing corporate functions, prioritizing business units and creating the nucleus of a world-class research and development organization. Agrinos continues to have a very attractive position in the biologicals segment for enhanced crop productivity, and our efforts to focus our business activities in core markets and develop a research and development team and facility in Davis, California, that enable our new product pipeline, will continue to support the growth of our position as a leader in biological crop nutrition solutions. I’m very excited by the company’s commercial, technological and organizational achievements in 2014. Bringing strong R&D and corporate professionals together in the U.S., and strengthening our Board of Directors with sector leaders such as Nick Adamchak, strengthens our competitive advantage in this rapidly emerging market and sets the stage for our strategic growth objects for 2015. I look forward to continuing the implementation of Agrinos’ sharpened commercial and technology development strategies as we enter 2015”, said Chief Executive Officer, D. Ry Wagner.

Agrinos’ interim report is available from the company’s website www.agrinos.com. The conference call material will be available on the website on April 8th, 2015 under Investor Relations, presentations.

Conference call
Agrinos will host a conference call for investors and analysts to discuss the interim report at 14:00 CET April 15, 2015. A presentation in support of the discussion is available on the company's web site under the investor releation, presentation section on April 8th, 2015. There will be no questions during the conference call. If there are any specific questions that investors would like to be answered please e-mail John Janczak CFO Agrions at john.janczak@agrinos.com. Questions received by Monday April 13 will be addressed.

Conference call-in details:

Dial in 5-10 minutes prior to the start time using the confirmation code and local numbers below.

Conference ID: 2239996

Phone numbers for local participants:
Oslo, Norway: +472316 2787
New York, United States of America: +1646 254 3364
London, United Kingdom: +44(0)20 3427 1918
Geneva, Switzerland: +41(0)22 592 7641
Sao Paulo, Brazil: +5511 3351 7250
Mumbai, India: +9122 6150 1504
Beijing, China: +861059 045 018
National free phone - Mexico: 001 877 550 9932

For further information, please contact:
John Janczak
Mobile: +1 817 507 6530

About Agrinos

Agrinos is a biological crop input provider committed to improving the productivity and sustainability of modern agriculture. Agrinos’ range of High Yield Technology®(“HYT®”) products helps farmers to practice profitable agriculture by providing increased crop productivity, improved efficiency of conventional fertilizer and a reduced environmental footprint.

Certified as organic and based on Agrinos’ proprietary technology, the HYT® products provide benefits by strengthening the soil-based microbial ecosystem, stimulating crop development at key points in the growth cycle and boosting natural plant resistance to pathogens and threats. With solutions for a variety of crop categories, the technology comprising the HYT® products has demonstrated its value in third-party trials in key agricultural regions worldwide.

Cautionary statement of forward-looking statements

This document contains certain forward-looking statements relating to the business, financial performance and results of the company and/or the industry in which it operates. Forward-looking statements concern future circumstances and results and other statements that are not historical facts, sometimes identified by the words “believes”, expects”, “predicts”, “intends”, “projects”, “plans”, “estimates”, “aims”, “foresees”, “anticipates”, “targets”, and similar expressions. The forward-looking statements contained in this announcement, including assumptions, opinions and views of the company or cited from third party sources are solely opinions and forecasts which are subject to risks, uncertainties and other factors that may cause actual events to differ materially from any anticipated development. Neither the company, nor any of its parent or subsidiary undertakings or any such person’s officers or employees provides any assurance that the assumptions underlying such forward-looking statements are free from errors nor does any of them accept any responsibility for the future accuracy of the opinions expressed in this announcement or the actual occurrence of the forecasted developments. No obligation, except as required by law, is assumed to update any forward-looking statements or to conform these forward-looking statements to our actual results.

« Return to News